Chemours (CC)
(Delayed Data from NYSE)
$19.57 USD
+0.34 (1.77%)
Updated Oct 4, 2024 04:00 PM ET
Pre-Market: $19.61 +0.04 (0.20%) 9:16 AM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.57 USD
+0.34 (1.77%)
Updated Oct 4, 2024 04:00 PM ET
Pre-Market: $19.61 +0.04 (0.20%) 9:16 AM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum F VGM
Zacks News
Implied Volatility Surging for Chemours (CC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
Chemours (CC) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not predict an earnings beat for Chemours (CC) this season.
Chemours' Opteon XP10 Refrigerants Chosen by Sharc Energy
by Zacks Equity Research
Chemours (CC) anticipates the collaboration to help Sharc Energy engage in refrigerant solutions that are more environmentally sustainable.
Implied Volatility Surging for Chemours (CC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
Chemours (CC) Down 22.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is the Options Market Predicting a Spike in Chemours (CC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
Chemours (CC) Earnings Top, Revenues Miss Estimates in Q3
by Zacks Equity Research
Illegal imports of HFC refrigerants and weaker demand for base refrigerants hurt Chemours' (CC) Fluoroproducts unit in Q3.
Chemours (CC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 5.36% and -0.19%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not conclusively predict that Chemours (CC) is likely to beat the Zacks Consensus Estimate this quarter.
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Down 22% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemours' (CC) Earnings and Revenues Miss Estimates in Q2
by Zacks Equity Research
Weak demand for Ti-Pure TiO2 and Illegal imports of HFC refrigerants hurt Chemours (CC) in Q2.
Chemours (CC) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of -20.00% and -7.97%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Chemours (CC) is expected to see some pressure on Ti-Pure TiO2 volumes in Q2.
Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours Inaugurates Opteon Facility, Boosts Production
by Zacks Equity Research
Chemours' (CC) new Texas-based facility will triple its production capacity of Opteon YF, which minimizes greenhouse gases.
Chemours (CC) Down 35% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemours' Opteon Refrigerants Selected by MEHITS Applications
by Zacks Equity Research
Chemours' (CC) Opteon XL41 is an A2L class refrigerant that offers the lowest GWP replacement solution.
Broad Markets Slide Again on Trade Woes
by David Borun
During a typically a slow week, US equities gave up ground again ans US-China trade talks stall
Zacks Value Trader Highlights: General Motors, General Electric, Chemours, Camping World and L Brands
by Zacks Equity Research
Zacks Value Trader Highlights: General Motors, General Electric, Chemours, Camping World and L Brands
Cheap Stock or Value Trap?
by Tracey Ryniec
How to spot value trap stocks.
Chemours' Opteon XL Selected by Carrier Transicold Europe
by Zacks Equity Research
Chemours' (CC) Opteon low GWP HFO refrigerants are a portfolio of versatile and sustainable refrigerants.
Chemours' (CC) Earnings, Revenues Trail Estimates in Q1
by Zacks Equity Research
Lower volumes in the Titanium Technologies unit and higher costs hurt Chemours' (CC) Q1 results.
This Week's Must-See Earnings Charts
by Tracey Ryniec
Which stocks will traders be watching this busy earnings week? These are some of those at the top of the list.
Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.